Dana-Farber study finds new drug for childhood cancer - National Cancer Institute
Links shared publicly online about this topic.
- 152total visits
Dana-Farber study finds new drug for childhood cancer - National Cancer Institute
View full resource at cancer.gov
Tags: Cancer, Leukemia, Drug, Healthcare, Hospital, Children's Health, Hospitals
Most Recently Shared on July 12, 2011 at 5:37 pm By:
Study by @DanaFarber finds epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer http://j.mp/plyynn
New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists - QualityPoint Technologies
qualitypointtech.net — “In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. The finding paves the way for the development of anti-diabetic therapeutics with minimal adverse side effects plaguing currently available drugs such as Avandia (rosiglitazone), scheduled to be removed from pharmacy shelves this fall due to concerns about increased risk of heart attack” View full resource at qualitypointtech.net
Most Recently Shared on September 6, 2011 at 9:45 am By:
New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists: In a joint study, scientists from ... http://t.co/H9HwmAg
Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer
labspaces.net — “A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA – so-called epigenetic changes – to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute. Together with collaborators from a biotechnology company, the same team also showed that a new drug tha” View full resource at labspaces.net
Most Recently Shared on July 11, 2011 at 6:30 pm By:
Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer - http://is.gd/w7Ejjg
Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-To-Treat Childhood Cancer
newswise.com — “A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA – so-called epigenetic changes – to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute. Together with collaborators from a biotechnology company, the same team also showed that a new drug that blocks these changes could deactivate cancer-promoting genes and halt the growth of this cancer.” View full resource at newswise.com
Most Recently Shared on July 11, 2011 at 4:33 pm By:
Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-To-Treat Childhood Cancer: A difficult-... http://bit.ly/nbeVAW #cancer
Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-To-Treat Childhood Cancer
newswise.com — “A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA – so-called epigenetic changes – to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute. Together with collaborators from a biotechnology company, the same team also showed that a new drug that blocks these changes could deactivate cancer-promoting genes and halt the growth of this cancer.” View full resource at newswise.com
Most Recently Shared on July 11, 2011 at 4:25 pm By:
newswise Health Communicator and Health News
Epigenetic Pathway and New Drug Show Promise in Reversing a Hard-To-Treat Childhood Cancer: A difficult-to-treat... http://bit.ly/ojplH8
Roche chief touts skin-cancer drug - BostonHerald.com
bostonherald.com — “Patients suffering from an aggressive form of advanced skin cancer are finding a new lease on life in a treatment discovered by researchers at Swiss pharmaceutical giant Roche, the firm’s chief executive told Hub business leaders yesterday. “The results are stunning,” Dr. Severin...” View full resource at bostonherald.com
Most Recently Shared on December 3, 2010 at 9:00 am By:
Study Explores Skin Cancer: A recent collaborative study by the Harvard-affiliated Dana-Farber Cancer Institute ... http://bit.ly/gx8XxQ
Advertisement
